GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (FRA:BBZA) » Definitions » E10

BB Biotech AG (FRA:BBZA) E10 : €5.25 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is BB Biotech AG E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

BB Biotech AG's adjusted earnings per share data for the three months ended in Dec. 2023 was €2.110. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €5.25 for the trailing ten years ended in Dec. 2023.

During the past 12 months, BB Biotech AG's average E10 Growth Rate was -1.30% per year. During the past 3 years, the average E10 Growth Rate was -1.60% per year. During the past 5 years, the average E10 Growth Rate was 4.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of BB Biotech AG was 11.40% per year. The lowest was -1.60% per year. And the median was 3.75% per year.

As of today (2024-05-21), BB Biotech AG's current stock price is €42.30. BB Biotech AG's E10 for the quarter that ended in Dec. 2023 was €5.25. BB Biotech AG's Shiller PE Ratio of today is 8.06.

During the past 13 years, the highest Shiller PE Ratio of BB Biotech AG was 9.01. The lowest was 5.62. And the median was 7.27.


BB Biotech AG E10 Historical Data

The historical data trend for BB Biotech AG's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG E10 Chart

BB Biotech AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.96 6.79 12.31 6.57 5.25

BB Biotech AG Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Dec17 Dec18 Dec19 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.57 5.86 4.64 4.84 5.25

Competitive Comparison of BB Biotech AG's E10

For the Biotechnology subindustry, BB Biotech AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BB Biotech AG's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's Shiller PE Ratio falls into.



BB Biotech AG E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BB Biotech AG's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.11/106.4612*106.4612
=2.110

Current CPI (Dec. 2023) = 106.4612.

BB Biotech AG Quarterly Data

per share eps CPI Adj_EPS
201106 -0.764 102.678 -0.792
201109 -1.173 101.811 -1.227
201112 1.190 101.408 1.249
201203 2.567 101.826 2.684
201206 1.808 101.596 1.895
201209 1.665 101.392 1.748
201212 -1.823 100.968 -1.922
201303 5.162 101.221 5.429
201306 1.852 101.466 1.943
201309 4.846 101.336 5.091
201312 1.442 101.036 1.519
201403 0.948 101.224 0.997
201406 2.831 101.517 2.969
201409 7.064 101.247 7.428
201412 10.674 100.704 11.284
201503 6.366 100.339 6.754
201506 5.735 100.464 6.077
201509 -9.455 99.785 -10.088
201512 8.441 99.386 9.042
201603 -19.908 99.475 -21.306
201606 0.588 100.088 0.625
201609 6.564 99.604 7.016
201612 -0.418 99.380 -0.448
201703 6.320 100.040 6.726
201706 1.719 100.285 1.825
201712 10.633 100.213 11.296
201812 -7.541 100.906 -7.956
201912 11.202 101.063 11.800
202012 11.547 100.241 12.264
202103 3.605 100.800 3.807
202106 2.121 101.352 2.228
202112 -7.024 101.776 -7.347
202203 -5.305 103.205 -5.472
202206 -4.124 104.783 -4.190
202209 3.974 104.835 4.036
202212 -0.649 104.666 -0.660
202303 -4.673 106.245 -4.683
202306 -0.246 106.576 -0.246
202309 -0.927 106.570 -0.926
202312 2.110 106.461 2.110

Add all the adjusted EPS together and divide 10 will get our e10.


BB Biotech AG  (FRA:BBZA) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

BB Biotech AG's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=42.30/5.25
=8.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of BB Biotech AG was 9.01. The lowest was 5.62. And the median was 7.27.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


BB Biotech AG E10 Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


BB Biotech AG (FRA:BBZA) Business Description

Traded in Other Exchanges
Address
Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.

BB Biotech AG (FRA:BBZA) Headlines

No Headlines